Hubei Biocause Pharmaceutical Co., Ltd. (000627) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Hubei Biocause Pharmaceutical Co., Ltd. Company Snapshot

Business Description:

Hubei Biocause Pharmaceutical Co., Ltd. operates in the Chemical preparations sector. Hubei Biocause Pharmaceutical Co., Ltd. is principally engaged in the manufacture of pharmaceuticals and chemical products. The Company provides its products through four segments: new energy chemicals, including coal derived methanol and dimethyl ether; synthetic resin, including polypropylene; drug substances and intermediates, including ibuprofen, dexibuprofen, oxaprozin, torasemide, gatifloxacin, balsatazide sodium, diosgenin, granisetron hydrochloride and fludarabine phosphate, and preparations, including pazufloxacin for injection, norfloxacin for injection, levofloxacin hydrochloride for injection and gastrodine for injection. The Company is also involved in the investment in insurance industry. In our complete report available for purchase the company is compared to: Weifang Yaxing Chemical Co., Ltd., Dymatic Chemicals Inc and Wanxiang International Limited.

Hubei Biocause Pharmaceutical Co., Ltd.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 2.91
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	3.2%

4 Weeks	-22.4%	52 Weeks	-39.2%

Hubei Biocause Pharmaceutical Co., Ltd. Key Data:

Ticker:	000627	Country:	CHINA

Exchanges:	SZN	Major Industry:	Chemicals

		Sub Industry:	Miscellaneous Chemicals

2010 Sales	1,261,159,000 (Year Ending Jan 2011).	Employees:	1,644

Currency:	Chinese Renmimbi	Market Cap:	3,938,946,510

Fiscal Yr Ends:	December	Shares Outstanding:	1,353,589,866

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.